US 12,440,126 B2
Temperature-compensated analyte monitoring devices, systems, and methods thereof
Gary A. Hayter, Oakland, CA (US); Daniel M. Bernstein, El Granada, CA (US); Martin J. Fennell, Concord, CA (US); Michael R. Love, Pleasanton, CA (US); Kenneth J. Doniger, Menlo Park, CA (US); Songbiao Zhang, Fremont, CA (US); Mark K. Sloan, Hayward, CA (US); Hyun Cho, Berkeley, CA (US); Theodore J. Kunich, Pleasanton, CA (US); Jean-Pierre Cole, Tracy, CA (US); Christopher A. Thomas, San Leandro, CA (US); Erwin S. Budiman, Fremont, CA (US); David L. Li, Fullerton, CA (US); Royce Cheng, San Francisco, CA (US); and Udo Hoss, San Ramon, CA (US)
Assigned to ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed by Abbott Diabetes Care Inc., Alameda, CA (US)
Filed on Jun. 23, 2023, as Appl. No. 18/340,779.
Application 15/873,464 is a division of application No. 13/526,394, filed on Jun. 18, 2012, granted, now 9,974,472, issued on May 22, 2018.
Application 18/340,779 is a continuation of application No. 18/152,619, filed on Jan. 10, 2023, granted, now 12,290,354.
Application 18/152,619 is a continuation of application No. 16/525,915, filed on Jul. 30, 2019, granted, now 11,571,147, issued on Feb. 7, 2023.
Application 16/525,915 is a continuation of application No. 15/873,464, filed on Jan. 17, 2018, granted, now 10,398,363, issued on Sep. 3, 2019.
Claims priority of provisional application 61/497,821, filed on Jun. 16, 2011.
Prior Publication US 2023/0346269 A1, Nov. 2, 2023
Int. Cl. A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61B 5/01 (2006.01); A61B 5/1473 (2006.01)
CPC A61B 5/14532 (2013.01) [A61B 5/01 (2013.01); A61B 5/14503 (2013.01); A61B 5/7225 (2013.01); A61B 5/1473 (2013.01); A61B 2560/0252 (2013.01); A61B 2562/0271 (2013.01)] 27 Claims
OG exemplary drawing
 
1. A method of determining a glucose level, the method comprising:
receiving a sensor signal from a glucose monitoring device, wherein the glucose monitoring device comprises a housing configured to be secured to a skin surface of a user by an adhesive, an in vivo glucose sensor coupled to the housing and comprising a first portion configured to be arranged above the skin surface and a second portion configured to be positioned below the skin surface and in contact with interstitial fluid, wherein the second portion comprises a working electrode and glucose sensing chemistry for sensing glucose levels;
receiving, by one or more processors coupled to the in vivo glucose sensor, a temperature measurement from a temperature sensor of the glucose monitoring device; and
determining, by the one or more processors, whether the temperature measurement exceeds a predetermined temperature threshold,
wherein when the temperature measurement does not exceed the predetermined temperature threshold, a temperature-compensated glucose sensor signal is determined by the one or more processors using the temperature measurement and the sensor signal, a glucose level based on the temperature-compensated glucose sensor signal is determined by the one or more processors, and the glucose level is displayed on a receiver in wireless communication with the glucose monitoring device, and
wherein when the temperature measurement exceeds the predetermined temperature threshold, the one or more processors wirelessly communicate an instruction to not display the glucose level on the receiver.